Sharing cross-reactive groups of MHC class I improves long-term graft survival

Yvo W.J. Sijpkens*, Ilias I.N. Doxiadis, Johan W. De Fijter, Marko J.K. Mallat, Leendert A. Van Es, Peter De Lange, Aeilko H. Zwinderman, Rudi G.J. Westendorp, Folkert J. Van Kemenade, Jan Anthonie Bruijn, Frans H.J. Claas, Leendert C. Paul

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)

Abstract

Background. Renal transplant loss from chronic rejection remains substantial. To increase our understanding of this syndrome, we identified risk factors predicting late graft loss, with a special emphasis on the impact of human lymphocyte antigen (HLA) matching. Methods. We studied all 654 cadaveric kidney transplants performed in our center between 1983 and 1996 that had survived for more than six months. Eighty-two transplants, lost because of chronic rejection, were used as the outcome variable. The influence of HLA mismatches and shares on long-term graft survival was evaluated at the level of private antigens and cross-reactive groups (CREG) of multiple histocompatibility complex (MHC) class I. HLA and other recipient, donors and transplant parameters were studied using univariate and multivariate Cox regression analysis. Results. The cohort had a mean number of 1.9 HLA mismatches. Because of the homozygosity of HLA antigens, HLA mismatches were not reciprocal to shares. CREG and HLA-A-B mismatches had a relative risk for graft loss of 1.19 (95% CI, 0.97 to 1.45) and 1.05 (0.84 to 1.32) per mismatch. In contrast, the relative risk per shared CREG and broad HLA-A-B antigen was 0.76 (0.63 to 0.92) and 0.79 (0.61 to 1.03). Multivariate analysis revealed that individuals sharing less than four CREGs had a relative risk of 2.13 (1.29 to 3.75) for late graft loss. Other independent predictors were a recipient age of less than 50 years, relative risk 1.95 (1.02 to 3.71); a donor age of more than 50 years, relative risk 1.68 (1.01 to 2.80); acute rejection (vascular vs. no rejection), relative risk 3.52 (1.72 to 7.18); proteinuria (dipstick > 1+ vs. negative), relative risk 2.86 (1.29 to 6.35); and a serum creatinine concentration of more than 150 μmol/liter at six months, relative risk 3.41 (1.96 to 5.94). Conclusion. We identified several coexisting recipient-, donor-, and transplant-related risk factors for graft loss from chronic rejection. In this well-matched group of renal transplants, HLA mismatches and shares had a nonreciprocal relationship. Sharing of HLA antigens, especially CREG of MHC class I, was associated with improved long-term survival.

Original languageEnglish
Pages (from-to)1920-1927
Number of pages8
JournalKidney International
Volume56
Issue number5
DOIs
Publication statusPublished - Nov 1999
Externally publishedYes

Fingerprint

Dive into the research topics of 'Sharing cross-reactive groups of MHC class I improves long-term graft survival'. Together they form a unique fingerprint.

Cite this